Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Anand Padmanabhan, Laura Connelly-Smith, Nicole Aqui, Rasheed A. Balogun, Reinhard Klingel, Erin Meyer, Huy P. Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D Zantek, Nancy M. Dunbar, Guest Editor Joseph Schwartz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.

Original languageEnglish (US)
Pages (from-to)171-354
Number of pages184
JournalJournal of clinical apheresis
Volume34
Issue number3
DOIs
StatePublished - Jun 1 2019

Fingerprint

Blood Component Removal
Evidence-Based Practice
Therapeutic Uses
Guidelines
Therapeutics

PubMed: MeSH publication types

  • Journal Article

Cite this

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis : The Eighth Special Issue. / Padmanabhan, Anand; Connelly-Smith, Laura; Aqui, Nicole; Balogun, Rasheed A.; Klingel, Reinhard; Meyer, Erin; Pham, Huy P.; Schneiderman, Jennifer; Witt, Volker; Wu, Yanyun; Zantek, Nicole D; Dunbar, Nancy M.; Schwartz, Guest Editor Joseph.

In: Journal of clinical apheresis, Vol. 34, No. 3, 01.06.2019, p. 171-354.

Research output: Contribution to journalArticle

Padmanabhan, A, Connelly-Smith, L, Aqui, N, Balogun, RA, Klingel, R, Meyer, E, Pham, HP, Schneiderman, J, Witt, V, Wu, Y, Zantek, ND, Dunbar, NM & Schwartz, GEJ 2019, 'Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue', Journal of clinical apheresis, vol. 34, no. 3, pp. 171-354. https://doi.org/10.1002/jca.21705
Padmanabhan, Anand ; Connelly-Smith, Laura ; Aqui, Nicole ; Balogun, Rasheed A. ; Klingel, Reinhard ; Meyer, Erin ; Pham, Huy P. ; Schneiderman, Jennifer ; Witt, Volker ; Wu, Yanyun ; Zantek, Nicole D ; Dunbar, Nancy M. ; Schwartz, Guest Editor Joseph. / Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis : The Eighth Special Issue. In: Journal of clinical apheresis. 2019 ; Vol. 34, No. 3. pp. 171-354.
@article{7086520e783f4316a8835d163e075113,
title = "Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue",
abstract = "The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.",
author = "Anand Padmanabhan and Laura Connelly-Smith and Nicole Aqui and Balogun, {Rasheed A.} and Reinhard Klingel and Erin Meyer and Pham, {Huy P.} and Jennifer Schneiderman and Volker Witt and Yanyun Wu and Zantek, {Nicole D} and Dunbar, {Nancy M.} and Schwartz, {Guest Editor Joseph}",
year = "2019",
month = "6",
day = "1",
doi = "10.1002/jca.21705",
language = "English (US)",
volume = "34",
pages = "171--354",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis

T2 - The Eighth Special Issue

AU - Padmanabhan, Anand

AU - Connelly-Smith, Laura

AU - Aqui, Nicole

AU - Balogun, Rasheed A.

AU - Klingel, Reinhard

AU - Meyer, Erin

AU - Pham, Huy P.

AU - Schneiderman, Jennifer

AU - Witt, Volker

AU - Wu, Yanyun

AU - Zantek, Nicole D

AU - Dunbar, Nancy M.

AU - Schwartz, Guest Editor Joseph

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.

AB - The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.

UR - http://www.scopus.com/inward/record.url?scp=85067539209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067539209&partnerID=8YFLogxK

U2 - 10.1002/jca.21705

DO - 10.1002/jca.21705

M3 - Article

C2 - 31180581

AN - SCOPUS:85067539209

VL - 34

SP - 171

EP - 354

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -